+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 134 Pages
  • May 2024
  • GlobalData
  • Pfizer Inc.
  • ID: 1314910
Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pfizer Inc (Pfizer) discovers, develops, manufactures, and commercializes biopharmaceuticals. The company offers products to treat various conditions such as cardiovascular, metabolic and pain, women’s health, cancer, inflammation, immune disorders, and rare diseases. It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer sells its products through wholesalers, retailers, hospitals, individual provider offices, clinics, government agencies, and pharmacies. It has major manufacturing facilities in India, China, Japan, Ireland, Italy, Belgium, Germany, Singapore, and the US. The company provides its products in North America, South America, Asia-Pacific, Australia, Europe, Africa, and the Middle East. Pfizer is headquartered in New York, the US.

Pfizer Inc Key Recent Developments

  • May 06, 2024: Pfizer Announces New Chief Strategy and Innovation Officer
  • May 02, 2024: Pfizer Reports First-Quarter 2024 Results
  • Apr 29, 2024: Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting
  • Apr 25, 2024: Pfizer Announces 2024 Shareholder Meeting Preliminary Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Pfizer Inc - Key Facts
  • Pfizer Inc - Key Employees
  • Pfizer Inc - Key Employee Biographies
  • Pfizer Inc - Major Products and Services
  • Pfizer Inc - History
  • Pfizer Inc - Company Statement
  • Pfizer Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Affiliate
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Pfizer Inc - Business Description
  • Business Segment: Biopharma
  • Overview
  • Performance
  • Business Segment: Business Innovation
  • Overview
  • Performance
  • Geographical Segment: Developed Europe
  • Target Markets
  • Performance
  • Geographical Segment: Developed Rest of World
  • Target Markets
  • Performance
  • Geographical Segment: Emerging Markets
  • Target Markets
  • Performance
  • Geographical Segment: United States
  • Performance
  • R&D Overview
  • Pfizer Inc - Corporate Strategy
  • Pfizer Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Pfizer Inc - Strengths
  • Pfizer Inc - Weaknesses
  • Pfizer Inc - Opportunities
  • Pfizer Inc - Threats
  • Pfizer Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Pfizer Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 06, 2024: Pfizer Announces New Chief Strategy and Innovation Officer
  • May 02, 2024: Pfizer Reports First-Quarter 2024 Results
  • Apr 29, 2024: Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting
  • Apr 25, 2024: Pfizer Announces 2024 Shareholder Meeting Preliminary Results
  • Apr 11, 2024: Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
  • Mar 28, 2024: Headlands Research Announces Fifth Research Site under Partnership with Pfizer to Improve Diversity in Clinical Trials
  • Mar 27, 2024: Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential
  • Feb 29, 2024: Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth
  • Feb 09, 2024: Pfizer Reports Un-audited Financial Results for the Quarter and Nine Months Ended 31st December, 2023
  • Feb 09, 2024: MHRA approvals for Comirnaty (Pfizer/BioNTech) and Nuvaxovid (Novavax) COVID-19 vaccines
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Pfizer Inc, Key Facts
  • Pfizer Inc, Key Employees
  • Pfizer Inc, Key Employee Biographies
  • Pfizer Inc, Major Products and Services
  • Pfizer Inc, History
  • Pfizer Inc, Subsidiaries
  • Pfizer Inc, Affiliate
  • Pfizer Inc, Joint Venture
  • Pfizer Inc, Key Competitors
  • Pfizer Inc, Ratios based on current share price
  • Pfizer Inc, Annual Ratios
  • Pfizer Inc, Annual Ratios (Cont...1)
  • Pfizer Inc, Annual Ratios (Cont...2)
  • Pfizer Inc, Interim Ratios
  • Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Pfizer Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Pfizer Inc, Performance Chart (2019 - 2023)
  • Pfizer Inc, Ratio Charts
  • Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Pfizer Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Takeda Pharmaceutical Co Ltd
  • Sanofi
  • Novartis AG
  • Eli Lilly and Co
  • AbbVie Inc
  • F. Hoffmann-La Roche Ltd
  • AstraZeneca Plc
  • Johnson & Johnson
  • Bristol-Myers Squibb Co
  • GSK plc
  • Amgen Inc
  • Merck & Co Inc
  • Dynavax Technologies Corp